SG10201405380QA - Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production - Google Patents
Endocrine precursor cells, pancreatic hormone-expressing cells and methods of productionInfo
- Publication number
- SG10201405380QA SG10201405380QA SG10201405380QA SG10201405380QA SG10201405380QA SG 10201405380Q A SG10201405380Q A SG 10201405380QA SG 10201405380Q A SG10201405380Q A SG 10201405380QA SG 10201405380Q A SG10201405380Q A SG 10201405380QA SG 10201405380Q A SG10201405380Q A SG 10201405380QA
- Authority
- SG
- Singapore
- Prior art keywords
- cells
- production
- methods
- endocrine precursor
- pancreatic hormone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
- C12N2501/734—Proteases (EC 3.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77864906P | 2006-03-02 | 2006-03-02 | |
US83363306P | 2006-07-26 | 2006-07-26 | |
US85287806P | 2006-10-18 | 2006-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201405380QA true SG10201405380QA (en) | 2014-10-30 |
Family
ID=38337162
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201405380QA SG10201405380QA (en) | 2006-03-02 | 2007-03-02 | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
SG201101559-1A SG170068A1 (en) | 2006-03-02 | 2007-03-02 | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201101559-1A SG170068A1 (en) | 2006-03-02 | 2007-03-02 | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
Country Status (9)
Country | Link |
---|---|
US (4) | US8129182B2 (en) |
EP (4) | EP2650360B1 (en) |
JP (10) | JP6110048B2 (en) |
AU (1) | AU2007224116B2 (en) |
CA (2) | CA2644468C (en) |
DK (3) | DK2650359T3 (en) |
NZ (1) | NZ571427A (en) |
SG (2) | SG10201405380QA (en) |
WO (1) | WO2007103282A2 (en) |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003014313A2 (en) * | 2001-08-06 | 2003-02-20 | Bresagen, Ltd. | Alternative compositions and methods for the culture of stem cells |
US20050266554A1 (en) * | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
JP5102030B2 (en) * | 2004-08-13 | 2012-12-19 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
PL1888123T3 (en) | 2005-06-08 | 2013-06-28 | Janssen Biotech Inc | A cellular therapy for ocular degeneration |
US20070122905A1 (en) | 2005-10-27 | 2007-05-31 | D Amour Kevin A | PDX1-expressing dorsal and ventral foregut endoderm |
EP1994141B1 (en) | 2006-02-23 | 2017-11-15 | ViaCyte, Inc. | Compositions and methods useful for culturing differentiable cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
WO2007103282A2 (en) | 2006-03-02 | 2007-09-13 | Cythera, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
AU2007277364B2 (en) | 2006-07-26 | 2010-08-12 | Viacyte, Inc. | Methods of producing pancreatic hormones |
US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
EP3957716A1 (en) * | 2007-07-18 | 2022-02-23 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
EP2185691B1 (en) * | 2007-07-31 | 2018-03-14 | Lifescan, Inc. | Pluripotent stem cell differentiation by using human feeder cells |
EP2185693B1 (en) * | 2007-07-31 | 2019-07-03 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
US9005962B2 (en) | 2007-08-24 | 2015-04-14 | The University Court Of The University Of Edinburgh | Regionalised endoderm cells and uses thereof |
US9062290B2 (en) * | 2007-11-27 | 2015-06-23 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
EP2227487A1 (en) | 2007-12-28 | 2010-09-15 | Novo Nordisk A/S | Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors |
SG154367A1 (en) * | 2008-01-31 | 2009-08-28 | Es Cell Int Pte Ltd | Method of differentiating stem cells |
MX2010009251A (en) | 2008-02-21 | 2010-11-25 | Centocor Ortho Biotech Inc | Methods, surface modified plates and compositions for cell attachment, cultivation and detachment. |
JP2011518547A (en) | 2008-04-03 | 2011-06-30 | ノボ・ノルデイスク・エー/エス | DNER-mediated cell purification of pancreatic endocrine pre-progenitor cells and their progeny |
US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
US7939322B2 (en) | 2008-04-24 | 2011-05-10 | Centocor Ortho Biotech Inc. | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm |
EP2297298A4 (en) * | 2008-05-09 | 2011-10-05 | Vistagen Therapeutics Inc | Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
CA2729734A1 (en) * | 2008-06-30 | 2010-01-07 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
ES2697798T3 (en) | 2008-06-30 | 2019-01-28 | Janssen Biotech Inc | Differentiation of pluripotent stem cells |
US8530245B2 (en) * | 2008-07-29 | 2013-09-10 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to acetylocholine receptor conjugates |
WO2010022395A2 (en) * | 2008-08-22 | 2010-02-25 | President And Fellows Of Harvard College | Methods of reprogramming cells |
WO2010030641A2 (en) * | 2008-09-10 | 2010-03-18 | The Regents Of The University Of Michigan | Pancreatic cancer markers |
WO2010037784A1 (en) * | 2008-09-30 | 2010-04-08 | Novo Nordisk A/S | G6pc2-encoded beta cell surface tags |
CN102333862B (en) | 2008-10-31 | 2018-04-27 | 詹森生物科技公司 | Differentiation of the human embryo stem cell to pancreatic endocrine pedigree |
CA2742268C (en) | 2008-10-31 | 2020-02-18 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
US8895300B2 (en) | 2008-11-04 | 2014-11-25 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
CA2742583C (en) | 2008-11-04 | 2022-09-27 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods for differentiation thereof |
JP2012508584A (en) | 2008-11-14 | 2012-04-12 | ヴィアサイト,インコーポレイテッド | Encapsulation of human pluripotent stem cell-derived pancreatic cells |
AU2009316580B2 (en) | 2008-11-20 | 2016-04-14 | Janssen Biotech, Inc. | Pluripotent stem cell culture on micro-carriers |
CA2744227C (en) | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
CN102307990A (en) | 2008-12-03 | 2012-01-04 | 国际干细胞公司 | Methods of deriving differentiated cells from stem cells |
WO2010085842A1 (en) * | 2009-01-27 | 2010-08-05 | Australian Stem Cell Centre Limited | Lung epithelial progenitor cells, uses thereof and processes for production |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
WO2010140464A1 (en) * | 2009-06-05 | 2010-12-09 | 国立大学法人 熊本大学 | Method for induction of cell differentiation |
US9388381B2 (en) | 2009-07-09 | 2016-07-12 | Massachusetts Institute Of Technology | Methods and compositions for increased safety of stem cell-derived populations |
EP2456858B1 (en) * | 2009-07-20 | 2018-08-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
GB2485113B (en) * | 2009-07-20 | 2016-12-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into cells of the pancreatic endoderm lineage |
KR20170118969A (en) * | 2009-07-20 | 2017-10-25 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
WO2011079017A2 (en) | 2009-12-23 | 2011-06-30 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
PL2516626T3 (en) * | 2009-12-23 | 2017-10-31 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
SG10201501503VA (en) | 2010-03-01 | 2015-04-29 | Janssen Biotech Inc | Methods for purifying cells derived from pluripotent stem cells |
RU2663339C1 (en) | 2010-05-12 | 2018-08-03 | Янссен Байотек, Инк. | Differentiation of human embryo stem cells |
DK2603226T3 (en) * | 2010-08-12 | 2021-06-07 | Janssen Biotech Inc | TREATMENT OF DIABETES WITH ENDOCRINE PANKREAS PRECURSOR ORCELLS |
BR112013004614A2 (en) | 2010-08-31 | 2024-01-16 | Janssen Biotech Inc | DIFFERENTIATION OF PLURIPOTENT STEM CELLS |
EP2611910B1 (en) | 2010-08-31 | 2018-01-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
EP3372672A1 (en) | 2010-08-31 | 2018-09-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
WO2012060109A1 (en) | 2010-11-05 | 2012-05-10 | Kyoto University | Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
WO2012081029A1 (en) * | 2010-12-15 | 2012-06-21 | Kadimastem Ltd. | Insulin producing cells derived from pluripotent stem cells |
US9433557B2 (en) | 2011-02-21 | 2016-09-06 | Viacyte, Inc. | Loading system for an encapsulation device |
CN108220224A (en) | 2011-06-21 | 2018-06-29 | 诺沃—诺迪斯克有限公司 | Definitive entoderm is effectively induced from pluripotent stem cell |
JP6441080B2 (en) | 2011-12-22 | 2018-12-19 | ヤンセン バイオテツク,インコーポレーテツド | Differentiation of human embryonic stem cells into single hormone insulin-positive cells |
CA2866590A1 (en) | 2012-03-07 | 2013-09-12 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
US9447378B2 (en) | 2012-04-27 | 2016-09-20 | Massachusetts Institute Of Technology | Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes |
PT2844739T (en) | 2012-04-30 | 2019-10-01 | Univ Health Network | Methods and compositions for generating pancreatic progenitors and functional beta cells from hpscs |
WO2013176249A1 (en) | 2012-05-25 | 2013-11-28 | 学校法人埼玉医科大学 | Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoter |
EP2859091B1 (en) | 2012-06-08 | 2018-08-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
JP6470687B2 (en) | 2012-09-03 | 2019-02-13 | ノヴォ ノルディスク アー/エス | Production of pancreatic endoderm from pluripotent stem cells using small molecules |
AU2013248265B2 (en) | 2012-11-08 | 2018-11-01 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
WO2014105543A1 (en) | 2012-12-31 | 2014-07-03 | Janssen Biotech, Inc. | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
RU2684215C2 (en) | 2012-12-31 | 2019-04-04 | Янссен Байотек, Инк. | Method for obtaining pancreatic endocrine cells (versions) and method for increasing output of beta cells |
MX2015008619A (en) | 2012-12-31 | 2016-01-12 | Janssen Biotech Inc | Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells. |
CN109394380B (en) | 2013-03-07 | 2023-03-10 | 韦尔赛特公司 | Three-dimensional high-capacity cell encapsulation device assembly |
USD720469S1 (en) | 2013-03-07 | 2014-12-30 | Viacyte, Inc. | Cell encapsulation device |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
AU2014239954B2 (en) * | 2013-03-15 | 2020-07-16 | The Jackson Laboratory | Isolation of non-embryonic stem cells and uses thereof |
US10266807B2 (en) | 2013-04-03 | 2019-04-23 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
JP6352908B2 (en) | 2013-05-24 | 2018-07-04 | 学校法人 埼玉医科大学 | Novel peptide and its use |
DE202014011287U1 (en) | 2013-06-11 | 2019-02-06 | The President And Fellows Of Harvard College | SC-β cells and compositions for producing the cells |
US9816070B2 (en) | 2013-06-14 | 2017-11-14 | Massachusetts Institute Of Technology | Articles and methods for stem cell differentiation |
JP6636427B2 (en) * | 2013-08-30 | 2020-01-29 | ノヴォ ノルディスク アー/エス | Generation of endocrine progenitor cells from human pluripotent stem cells using small molecules |
CA2931334A1 (en) * | 2013-11-21 | 2015-05-28 | Memorial Sloan-Kettering Cancer Center | Specification of functional cranial placode derivatives from human pluripotent stem cells |
EP2896688A1 (en) * | 2014-01-20 | 2015-07-22 | Centre National de la Recherche Scientifique (CNRS) | A method of producing beta pancreatic cells from progenitor cells through the use of hydrogen peroxide |
US11051900B2 (en) | 2014-04-16 | 2021-07-06 | Viacyte, Inc. | Tools and instruments for use with implantable encapsulation devices |
JP6588969B2 (en) | 2014-05-16 | 2019-10-09 | ヤンセン バイオテツク,インコーポレーテツド | Use of small molecules to enhance MAFA expression in pancreatic endocrine cells |
EP3234110B1 (en) | 2014-12-18 | 2024-02-28 | President and Fellows of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF |
CN107614678B (en) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | Method for producing stem cell-derived beta cells and method for using same |
WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
RU2017125728A (en) * | 2014-12-19 | 2019-01-22 | Янссен Байотек, Инк. | CULTIVATION OF PLURIPOTENT STEM CELLS IN SUSPENSION |
CN107787363B (en) | 2015-04-24 | 2021-06-25 | 哥本哈根大学 | Isolation of true pancreatic progenitor cells |
JP6441256B2 (en) * | 2016-04-13 | 2018-12-19 | バイアサイト インク | Stem cell assembly suspension composition and differentiation method thereof |
MA45479A (en) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE |
WO2018089011A1 (en) | 2016-11-10 | 2018-05-17 | Viacyte, Inc | Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
EP3409239A1 (en) | 2017-05-29 | 2018-12-05 | University College Dublin, National University of Ireland, Dublin | An implantable active agent encapsulating device |
AU2018285539A1 (en) | 2017-06-14 | 2020-02-06 | Vertex Pharmaceuticals Incorporated | Devices and methods for delivering therapeutics |
US10391156B2 (en) | 2017-07-12 | 2019-08-27 | Viacyte, Inc. | University donor cells and related methods |
CA2983845C (en) | 2017-10-26 | 2024-01-30 | University Of Copenhagen | Generation of glucose-responsive beta cells |
AU2018370029A1 (en) | 2017-11-15 | 2020-07-02 | Vertex Pharmaceuticals Incorporated | Islet cell manufacturing compositions and methods of use |
WO2019142883A1 (en) | 2018-01-18 | 2019-07-25 | 第一三共株式会社 | Dihydroindolizinone derivative |
JP7311116B2 (en) * | 2018-04-27 | 2023-07-19 | 株式会社カネカ | Method for producing pancreatic β-cells |
CA3101021A1 (en) | 2018-05-31 | 2019-12-05 | University Health Network | Methods and compositions comprising tankyrase inhibitors for generating insulin producing cells |
WO2020033879A1 (en) | 2018-08-10 | 2020-02-13 | Semma Therapeutics, Inc. | Stem cell derived islet differentiation |
KR102069635B1 (en) | 2018-09-06 | 2020-02-24 | 삼성전기주식회사 | Coil component |
US10724052B2 (en) | 2018-09-07 | 2020-07-28 | Crispr Therapeutics Ag | Universal donor cells |
CN112867787A (en) * | 2018-09-19 | 2021-05-28 | 武田药品工业株式会社 | Insulin producing cells |
WO2020243665A1 (en) | 2019-05-31 | 2020-12-03 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
EP3975926A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates, Inc. | A biocompatible membrane composite |
EP3976237A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates Inc. | Cell encapsulation devices with controlled oxygen diffusion distances |
EP3976236A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates Inc. | A biocompatible membrane composite |
CA3150235A1 (en) | 2019-09-05 | 2021-03-11 | Alireza Rezania | Universal donor cells |
CN114364791A (en) | 2019-09-05 | 2022-04-15 | 克里斯珀医疗股份公司 | Universal donor cell |
EP4271796A1 (en) | 2020-12-31 | 2023-11-08 | CRISPR Therapeutics AG | Universal donor cells |
WO2023164171A2 (en) | 2022-02-25 | 2023-08-31 | Viacyte, Inc. | Multilayer implantable cell encapsulation devices and methods thereof |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2161804A (en) | 1935-11-09 | 1939-06-13 | Baldwin Southwark Corp | Hydraulic press |
US6165993A (en) | 1992-03-23 | 2000-12-26 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
US5690926A (en) | 1992-10-08 | 1997-11-25 | Vanderbilt University | Pluripotential embryonic cells and methods of making same |
US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US7153684B1 (en) | 1992-10-08 | 2006-12-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
US6015671A (en) | 1995-06-07 | 2000-01-18 | Indiana University Foundation | Myocardial grafts and cellular compositions |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
WO1997032033A1 (en) | 1996-02-28 | 1997-09-04 | Vanderbilt University | Compositions and methods of making embryonic stem cells |
US5964261A (en) | 1996-05-29 | 1999-10-12 | Baxter International Inc. | Implantation assembly |
WO1998030679A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
US6090622A (en) | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
ES2279580T3 (en) | 1997-09-15 | 2007-08-16 | Genetic Immunity, Llc | COMPOSITIONS FOR MANAGING GENES TO SKIN CELLS THAT PRESENT ANTIGENS. |
AU1197699A (en) | 1997-10-23 | 1999-05-10 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
US6921811B2 (en) | 1998-09-22 | 2005-07-26 | Biosurface Engineering Technologies, Inc. | Bioactive coating composition and methods |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
DE19852800C1 (en) | 1998-11-16 | 2000-04-13 | Univ Albert Ludwigs Freiburg | Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide |
AU780794B2 (en) | 1999-02-10 | 2005-04-14 | Es Cell International Pte Ltd | Pancreatic progenitor cells, methods and uses related thereto |
US6872389B1 (en) | 1999-07-08 | 2005-03-29 | Rhode Island Hospital | Liver stem cell |
US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
US7256042B2 (en) | 2000-04-27 | 2007-08-14 | Geron Corporation | Process for making hepatocytes from pluripotent stem cells |
IL154159A0 (en) | 2000-08-01 | 2003-07-31 | Yissum Res Dev Co | Directed differentiation of ebryonic cells |
WO2002034880A2 (en) | 2000-10-23 | 2002-05-02 | University Of Kansas | Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion |
JP2005503759A (en) * | 2001-01-24 | 2005-02-10 | アメリカ合衆国 | Differentiation of stem cells into pancreatic endocrine cells |
TW534580U (en) * | 2001-03-29 | 2003-05-21 | Delta Electronics Inc | Foldable handle |
CA2447015A1 (en) * | 2001-05-15 | 2002-11-21 | Rappaport Family Institute For Research In The Medical Sciences | Insulin producing cells derived from human embryonic stem cells |
AU2002345691C1 (en) | 2001-06-13 | 2008-07-24 | Massachusetts Institute Of Technology | In vivo bioreactors |
EP1298201A1 (en) | 2001-09-27 | 2003-04-02 | Cardion AG | Process for the production of cells exhibiting an islet-beta-cell-like state |
JP2005510232A (en) * | 2001-11-26 | 2005-04-21 | アドバンスド セル テクノロジー、インク. | Production and use of reprogrammed human somatic cell nuclei and autologous and syngeneic human stem cells |
AU2002351238B2 (en) * | 2001-12-04 | 2009-01-08 | Organogenesis Inc. | Cultured cells from pancreatic islets |
US7157278B2 (en) * | 2001-12-04 | 2007-01-02 | Organogenesis, Inc. | Cultured cells from pancreatic islets |
EP2264146A1 (en) * | 2001-12-07 | 2010-12-22 | Geron Corporation | Islet cells from human embryonic stem cells |
US20030138949A1 (en) | 2001-12-12 | 2003-07-24 | Anil Bhushan | Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells |
SG141296A1 (en) | 2002-05-17 | 2008-04-28 | Sinai School Medicine | Mesoderm and definitive endoderm cell populations |
US20060003446A1 (en) | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
JP2006512046A (en) | 2002-05-28 | 2006-04-13 | ベクトン・ディキンソン・アンド・カンパニー | Methods for proliferation of human pancreatic acinar cells and transdifferentiation into insulin producing cells in vitro |
AU2003240810A1 (en) | 2002-05-28 | 2003-12-12 | Becton, Dickinson And Company | Methods, compositions, and growth and differentiation factors for insulin-producing cells |
EP1539928A4 (en) * | 2002-09-06 | 2006-09-06 | Amcyte Inc | Cd56 positive human adult pancreatic endocrine progenitor cells |
EP1567639A4 (en) | 2002-12-05 | 2005-12-21 | Technion Res & Dev Foundation | Cultured human pancreatic islets, and uses thereof |
FR2849043B1 (en) * | 2002-12-24 | 2005-07-08 | Gemac | METHOD FOR MANUFACTURING AN ACTIVE MOLECULE VECTOR APPLICABLE IN THE FIELD OF DIFFUSION OF ACTIVE PRINCIPLES AND VECTOR OBTAINED |
EP1594954A4 (en) | 2003-02-07 | 2010-01-27 | Wisconsin Alumni Res Found | Directed genetic modifications of human stem cells |
US20070154981A1 (en) | 2003-02-14 | 2007-07-05 | The Board Of Trustees Of The Leland Stanford Junior University | Insulin-producing cells derived from stem cells |
US20030224411A1 (en) | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
US20040229350A1 (en) | 2003-05-12 | 2004-11-18 | Nikolai Strelchenko | Morula derived embryonic stem cells |
US20060281136A1 (en) | 2003-05-20 | 2006-12-14 | Shinichi Nishikawa | Preparation of endodermal stem cells |
WO2005017131A2 (en) | 2003-08-14 | 2005-02-24 | THE GOUVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT F HEALTH AND HUMAN SERVICES | Methods for the differentiation of human stem cells |
WO2005033294A2 (en) | 2003-09-30 | 2005-04-14 | Regents Of The University Of California | Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage |
WO2005059095A2 (en) * | 2003-12-10 | 2005-06-30 | The General Hospital Corporation | Expansion and differentiation of islet progenitor cells |
US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
US8647873B2 (en) * | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
US8586357B2 (en) | 2003-12-23 | 2013-11-19 | Viacyte, Inc. | Markers of definitive endoderm |
US7704738B2 (en) | 2003-12-23 | 2010-04-27 | Cythera, Inc. | Definitive endoderm |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
US20050266554A1 (en) * | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
ATE459883T1 (en) | 2004-02-27 | 2010-03-15 | Inst Curie | NEW PROLIFERATION MARKERS IN CLINICAL PRACTICE AND THEIR USE FOR CANCER PROGNOSIS OR DIAGNOSIS |
AU2005221095A1 (en) | 2004-03-09 | 2005-09-22 | John J. O'neil | Methods for generating insulin-producing cells |
WO2005097980A2 (en) | 2004-03-26 | 2005-10-20 | Geron Corporation | New protocols for making hepatocytes from embryonic stem cells |
WO2005097977A2 (en) | 2004-04-01 | 2005-10-20 | Wisconsin Alumni Research Foundation | Differentiation of stem cells to endoderm and pancreatic lineage |
JP4926946B2 (en) * | 2004-04-27 | 2012-05-09 | ヴィアサイト,インコーポレイテッド | PDX1-expressing endoderm |
JP5687816B2 (en) | 2004-07-09 | 2015-03-25 | ヴィアサイト,インコーポレイテッド | Methods for identifying factors for differentiating definitive endoderm |
CA2573354C (en) | 2004-07-09 | 2015-02-24 | Cythera, Inc. | Preprimitive streak and mesendoderm cells |
JP5102030B2 (en) | 2004-08-13 | 2012-12-19 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
CA2580798A1 (en) | 2004-09-29 | 2006-04-06 | Cellartis Ab | Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
AU2006210955A1 (en) * | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
CN100425694C (en) | 2005-04-15 | 2008-10-15 | 北京大学 | Method of inducing embryo stem cell to differentiate toward pancreatic cell |
WO2007002210A2 (en) | 2005-06-20 | 2007-01-04 | Bresagen, Inc. | Embryonic stem cell culture compositions and methods of use thereof |
US20070122905A1 (en) | 2005-10-27 | 2007-05-31 | D Amour Kevin A | PDX1-expressing dorsal and ventral foregut endoderm |
GB0602063D0 (en) | 2006-02-02 | 2006-03-15 | Univ Manchester | Cell Culture |
WO2007103282A2 (en) | 2006-03-02 | 2007-09-13 | Cythera, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
AU2007277364B2 (en) | 2006-07-26 | 2010-08-12 | Viacyte, Inc. | Methods of producing pancreatic hormones |
WO2008016999A2 (en) | 2006-08-01 | 2008-02-07 | The Regents Of The University Of California | Fermentation system having strainer assembly |
US20080241250A1 (en) | 2006-11-08 | 2008-10-02 | Emans Pieter J | In vivo bioreactors and methods of making and using same |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
WO2009154606A1 (en) * | 2008-06-03 | 2009-12-23 | Cythera, Inc. | Growth factors for production of definitive endoderm |
US11586805B2 (en) | 2021-07-26 | 2023-02-21 | Atlassian Pty Ltd. | Machine-learning-based natural language processing techniques for low-latency document summarization |
-
2007
- 2007-03-02 WO PCT/US2007/005541 patent/WO2007103282A2/en active Application Filing
- 2007-03-02 CA CA2644468A patent/CA2644468C/en active Active
- 2007-03-02 EP EP13159719.7A patent/EP2650360B1/en active Active
- 2007-03-02 JP JP2008557431A patent/JP6110048B2/en active Active
- 2007-03-02 US US11/681,687 patent/US8129182B2/en active Active
- 2007-03-02 EP EP07752255.5A patent/EP1999253B1/en active Active
- 2007-03-02 DK DK13159712.2T patent/DK2650359T3/en active
- 2007-03-02 NZ NZ571427A patent/NZ571427A/en not_active IP Right Cessation
- 2007-03-02 SG SG10201405380QA patent/SG10201405380QA/en unknown
- 2007-03-02 EP EP22171067.6A patent/EP4112718A1/en active Pending
- 2007-03-02 AU AU2007224116A patent/AU2007224116B2/en active Active
- 2007-03-02 DK DK13159719.7T patent/DK2650360T3/en active
- 2007-03-02 DK DK07752255.5T patent/DK1999253T3/en active
- 2007-03-02 CA CA3147112A patent/CA3147112A1/en active Pending
- 2007-03-02 EP EP13159712.2A patent/EP2650359B1/en active Active
- 2007-03-02 SG SG201101559-1A patent/SG170068A1/en unknown
-
2011
- 2011-10-17 US US13/275,274 patent/US8603811B2/en active Active
-
2013
- 2013-11-05 US US14/072,491 patent/US20140154801A1/en not_active Abandoned
- 2013-11-25 JP JP2013242867A patent/JP2014079247A/en active Pending
-
2015
- 2015-08-03 JP JP2015153742A patent/JP6339980B2/en active Active
-
2016
- 2016-05-13 JP JP2016096963A patent/JP6804866B2/en active Active
- 2016-06-03 US US15/173,316 patent/US10370645B2/en active Active
-
2017
- 2017-02-09 JP JP2017022606A patent/JP6574212B2/en active Active
-
2018
- 2018-10-15 JP JP2018194658A patent/JP2019022517A/en active Pending
-
2019
- 2019-11-27 JP JP2019214611A patent/JP7409839B2/en active Active
-
2021
- 2021-04-19 JP JP2021070464A patent/JP2021101747A/en active Pending
-
2022
- 2022-07-26 JP JP2022118466A patent/JP2022136183A/en active Pending
-
2024
- 2024-01-11 JP JP2024002853A patent/JP2024026731A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201405380QA (en) | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production | |
EP2084771A4 (en) | Methods and apparatuses for continuous manufacturing of fuel cells. | |
HK1136612A1 (en) | Rekeyable lock assembly and method of operation | |
EP1857532A4 (en) | Solid biomass and method for production thereof | |
ZA200906751B (en) | Enzyme for the production of methylmalonyl coenzyme A or ethylmalonyl coenzyme A, and use thereof | |
HK1141026A1 (en) | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof -2- | |
IL182940A0 (en) | Solid electrolyte and method of producing the same | |
EP2255263A4 (en) | Redriver with two reference clocks and method of operation thereof | |
HK1140202A1 (en) | Novel pyridopyrazine derivatives, process of manufacturing and uses thereof | |
EP2149153A4 (en) | Contact and method of fabrication | |
EP2072070A4 (en) | Substrate and method for production thereof | |
EP1983969A4 (en) | Low-moisture-content hard capsule and production method therefor | |
IL193726A0 (en) | Solid hydrogen fuel elements and methods of making the same | |
EP2187073A4 (en) | Bearing structure, and its manufacturing method | |
ZA200901467B (en) | Ceramic armoring and method for the production of ceramic armoring | |
AU2014200153B2 (en) | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production | |
TWI319610B (en) | Method of manufacturing openings and via openings | |
EP2138578A4 (en) | Reductase, gene thereof and method of using the same | |
GB0700188D0 (en) | Fuel and method of production thereof | |
PL382735A1 (en) | Colourful polysaccharines and production method of colourful polysaccharines | |
PL381294A1 (en) | New poly(3-alkylotiophenes) and their production method | |
AU2006902571A0 (en) | Paint-modifying roller and method of manufacture | |
PL384117A1 (en) | New poly [di-heptynodimethylosilane] and its production method | |
PL383357A1 (en) | Production method of quantum points and other oxide-zink nanomolecules | |
PL379453A1 (en) | Polystyrene compound with reduced combustibility and method for the manufacture of polystyrene compound with reduced combustibility |